How treatment priorities influence triptan preferences in clinical practice: perspectives of migraine sufferers, neurologists, and primary care physicians

References

• MacGregor EA, Brandes J, Eikermann A. Migraine prevalence and treatment patterns: the global Migraine and Zolmitriptan Evaluation survey. Headache 2003;43(1):19–26
   Google Scholar
• Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001;41(7):646–57
   Google Scholar
• Steiner TJ, Scher AI, Stewart WF, Kolodner K, Liberman J, Lipton RB. The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicity. Cephalalgia 2003;23(7):519–27
   PubMed Web of Science ®Google Scholar
• Lipton RB, Diamond S, Reed M, Diamond ML, Stewart WF. Migraine diagnosis and treatment: results from the American Migraine Study II. Headache 2001;41(7):638–45
   Google Scholar
• Gallagher RM, Kunkel R. Migraine medication attributes important for patient compliance: concerns about side effects may delay treatment. Headache 2003;43:36–44
   PubMed Web of Science ®Google Scholar
• Lipton RB, Stewart WF. Acute migraine therapy: do doctors understand what patients with migraine want from therapy? Headache 1999;39(Suppl 2):S20–S26
   Google Scholar
• Deleu D, Hanssens Y, Worthing EA. Symptomatic and prophylactic treatment of migraine: a critical reappraisal. Clin Neuropharmacol 1998;21(5):267–79
   Google Scholar
• Dahlof C. Integrating the triptans into clinical practice. Curr Opin Neurol 2002;15(3):317–22
   PubMed Web of Science ®Google Scholar
• Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000;55(6):754–62
   PubMed Web of Science ®Google Scholar
• Ferrari MD, Roon KI, Lipton RB, Goadsby PJ. Oral triptans (serotonin 5-HT D agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet 2001;358:1668–75
   PubMed Web of Science ®Google Scholar
• Ferrari MD, Goadsby PJ, Roon KI, Lipton RB. Triptans (serotonin, 5-HT agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalalgia 2002;22:633–58
   PubMed Web of Science ®Google Scholar
• Goadsby PJ, Lipton RB, Ferrari MD. Migraine - current understanding and treatment. New Engl J Med 2002; 346:257–70
   PubMed Web of Science ®Google Scholar
• von Winterfeldt D, Edwards W. Decision analysis and behavioral research. Cambridge: Cambridge University Press; 1987
   Google Scholar
• Brodie MJ, Kwan P. The Star Systems: overview and use in determining antiepileptic drug choice. CNS Drugs 2001; 15(1):1–12
   PubMed Web of Science ®Google Scholar
• Azar F. Multiattribute decision making: use of three scoring methods to compare the performance of imaging techniques for breast cancer detection. Available at: http://www.cis.upenn. edu/~fredazar/publications/pdf/fredazar_techreport_MS-CIS- 00–10.PDF [accessed October 21, 2002]
   Google Scholar
• Ferrari MD. Tripstar: a comprehensive patient-based approach to compare triptans. Headache 2002;42( Suppl 1):18–25
   PubMedGoogle Scholar
• Schumacher GE. Multiattribute evaluation in formulary decision making as applied to calcium-channel blockers. Am J Hosp Pharm 1991;48(2):301–8
   PubMedGoogle Scholar
• Eriksen S, Keller LR. A multiattribute-utility-function approach to weighing the risks and benefits of pharmaceutical agents. Med Decis Mak 1993;13(2):118–25
   PubMed Web of Science ®Google Scholar
• Dolan JG, Bordley DR. Isoniazid prophylaxis: the importance of individual values. Med Decis Making 1994;14(1):1–8
   PubMed Web of Science ®Google Scholar
• Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology 2001;56(6 Suppl 1):S20–S28
   Google Scholar
• Holmes WF, MacGregor EA, Sawyer JP, Lipton RB. Information about migraine disability influences physicians' perceptions of illness severity and treatment needs. Headache 2001;41(4): 343–50
   PubMed Web of Science ®Google Scholar
• Lipton RB, Stewart WF, Stone AM, Lainez MJ, Sawyer JP. Stratified care vs step care strategies for migraine: the Disability in Strategies of Care (DISC) Study: a randomized trial. J Am Med Assoc 2000;284(20):2599–605
   Google Scholar
• Lipton R, Liberman J, Cutrer F, et al. Treatment preferences and the selection of acute migraine medications: results from a population-based survey. J Headache Pain 2004;5(2):123–30
   Google Scholar
• Dolan JG, Isselhardt Jr BJ, Cappuccio JD. The analytic hierarchy process in medical decision making: a tutorial. Med Decis Making 1989;9(1):40–50
   PubMed Web of Science ®Google Scholar
• Mooney CZ, Duval RD. Bootstrapping: a nonparametric approach to statistical interference. Newbury Park (CA): Sage Publications; 1993
   Google Scholar
• Anon. American Medical Association Physician Characteristics and Distribution in the US. Chicago (IL): American Medical Association; 2001
   Google Scholar
• Health Resources and Services Administration - Bureau of Health Professions. State health workforce profiles. Available at: http://bhpr.hrsa.gov/healthworkforce/reports/profiles/default. htm. [accessed January 14, 2003]
   Google Scholar
• Dodick D, Lipton RB, Ferrari M, et al. Prioritizing treatment attributes and their impact on selecting an oral triptan: Results from the TRIPSTAR project. Curr Pain Headache Rep 2004;8: 435–42
   Google Scholar
• Cutrer FM, Goadsby PJ, Ferrari MD, Lipton RB, Dodick DW, McCrory D. Priorities for triptan treatment attributes and their implications for selecting an oral triptan for acute migraine: a study of US primary care physicians (the TRIPSTAR project). Clin Ther 2004;26:1533–45
   PubMed Web of Science ®Google Scholar
• Hwang C-L, Yoon KP. Multiattribute decision making: methods and applications. Berlin: Springer; 1981. p. 128–40
   Google Scholar
• Yoon KP Hwang C-L. Multiple attribute decision making: an introduction. Thousand Oaks: Sage; 1995. p. 38–40
   Google Scholar
• Zeleny M. Multiple criteria decision making. New York: McGraw Hill; 1982
   Google Scholar
• Deng H, Yeh C-H, Willis RJ. Inter-company comparison using modified TOPSIS with objective weights. Comput Operations Res 2000;27:963–73
   Google Scholar
• Roon KI, Lipton R, Goadsby PJ, Ferrari M. Placebo in triptan trials: efficacy, tolerability and consistency. Cephalalgia 2001;21: 405–32
   Google Scholar
• Baltussen RM, Hutubessy RC, Evans DB, Murray CJ. Uncertainty in cost-effectiveness analysis. Probabilistic uncertainty analysis and stochastic league tables. Int J Technol Assess Health Care 2002;18(1):112–9
   Google Scholar
• Washington State Department of Health. Guidelines for using confidence intervals for public health assessment. Website: http://www.doh.wa.gov/Data/Guidelines/ConfIntguide.htm [accessed 16th December 2004]
   Google Scholar
• Dodick DW Lipton RB, Goadsby PJ, et al. Prioritizing triptan treatment attributes: a pilot study. Neurology 2002;58(Suppl 3): A129
   Google Scholar
• McCrory D, Williams P. Selecting the preferred triptans. J Headache Pain 2004;5:247–50
   Google Scholar
• Ferrari MD, Goadsby PJ, Lipton RB. The use of multiattribute decision models in evaluating triptan treatment options in migraine. J Neurol [in press]
   Google Scholar
• Lipton RB, Bigal ME, Rush SR, et al. Migraine practice patterns among neurologists. Neurology 2004;62:1926–31
   PubMed Web of Science ®Google Scholar
• Moss L, Goldstein H. The recall method in social surveys. London: University of London Institute of Education; 1979
   Google Scholar
• Abi-Zeid I, Belanger M, Guitouni A, Martel J-M, Jabeur K. A multicriteria method for evaluating courses of action in Canadian airspace violation situations. Paper presented at: Fourth International Symposium on command and Control Research and Technology; June, 1998; Nasby Slott, Sweden
   Google Scholar
• Dayno JM, Lipton RB. Acute migraine treatment: factors affecting therapeutic decision making. Cephalalgia 2001;21:320–1
   Google Scholar
• Trowbridge R, Weingarten S. Clinical decision support systems, Chapter 53. In: Evidence report/technology assessment no. 43, making health care safer: a critical analysis of patient safety practices. Agency for Healthcare Research and Quality, Washington. Available at: http://www.premierinc.com/all/safety/resources/patient_safety/downloads/23_AHRQ_evidence_ report_43.pdf [accessed December 5, 2003]
   Google Scholar
• Purdy RA. Evidence-based migraine therapy: learning needs and knowledge assessment. Cephalalgia 2000;20(Suppl 2):5–9
   PubMedGoogle Scholar
• Pascual J. Clinical benefits of early triptan therapy for migraine. Headache 2002;42(Suppl 1):S10–S17
   Google Scholar
• Mathew NT. Early intervention with almotriptan improves sustained pain-free responses in acute migraine. Headache 2003;43:1075–9
   PubMed Web of Science ®Google Scholar